Case Study: Building an Economically Viable Path for Gene Therapy in Osteoarthritis
- Leveraging novel vectors to reduce cost of goods and create greater economic value
- Understanding how proactive payer engagement and early market education can pave the way for smoother commercialization
- Exploring how cross-functional collaboration and continuous learning have shaped a resilient development strategy capable of navigating scientific, clinical, and economic hurdles